Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 60472-60473 [2014-23855]

Download as PDF 60472 Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of responses per respondent Number of respondents Average burden per response (in hours) Total burden hours Type of respondent Form name Site Coordinator ................................ Site Coordinator Interview Guide ..... 18 1 1.5 27 Total ........................................... ........................................................... ........................ ........................ ........................ 72 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention [FR Doc. 2014–23865 Filed 10–6–14; 8:45 am] Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES The meeting announced below concerns Workers’ Compensation Surveillance, PAR14–227, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Centers for Disease Control and Prevention asabaliauskas on DSK5VPTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the charter for the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through September 18, 2016. For information, contact Catherine Ramadei, Acting Designated Federal Officer, Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road NE., Mailstop K48, Atlanta, Georgia 30333, telephone (770) 488– 4796 or fax (404) 248–4152. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Time and Date: 11:00 a.m.–7:00 p.m., November 5, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Workers’ Compensation Surveillance, PAR14–227, initial review.’’ Contact Person for More Information: Donald Blackman, Ph.D., Scientific Review Officer, CDC, 2400 Century Center Parkway NE., 4th Floor, Room 4204, Mailstop E–74, Atlanta, Georgia 30345, Telephone: (404) 498–6185, DYB7@CDC.GOV . The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–23854 Filed 10–6–14; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2014–23858 Filed 10–6–14; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 17:15 Oct 06, 2014 Jkt 235001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 8:15 a.m.–4:30 p.m., Pacific Daylight Time, November 6, 2014. Public Comment Time and Date: 4:30 p.m.–5:30 p.m., Pacific Daylight Time, November 6, 2014. Place: Hilton Garden Inn Los Angeles/ Redondo Beach, 2410 Marine Avenue, Redondo Beach, CA 90278, Phone: 310– 727–9999; Fax: 310–727–9998. Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in number is 1– 866–659–0537 with a pass code of 9933701. Live Meeting Connection: https:// www.livemeeting.com/cc/cdc/join?id= ZN5GQZ&role=attend&pw=ABRWH; Meeting ID: ZN5GQZ; Entry Code: ABRWH. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 100 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific E:\FR\FM\07OCN1.SGM 07OCN1 asabaliauskas on DSK5VPTVN1PROD with NOTICES Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2015. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters for Discussion: The agenda for the Advisory Board meeting includes: NIOSH Program Update; Department of Labor Program Update; Department of Energy Program Update; SEC Issues Work Group Report on ‘‘Sufficient Accuracy’’/Co-Worker Dose Modeling; SEC Petitions Update; an update on SEC and Site Profile work for the Area IV of the Santa Susana Field Laboratory (Ventura County, CA); and Board Work Session. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted to the contact person below well in advance of the meeting. Any written comments received will be provided at the meeting in accordance with the redaction policy provided below. Policy on Redaction of Board Meeting Transcripts (Public Comment): (1) If a person making a comment gives his or her personal information, no attempt will be made to redact the name; however, NIOSH will redact other personally identifiable information, such as contact information, social security numbers, case numbers, etc., of the commenter. (2) If an individual in making a statement reveals personal information (e.g., medical or employment VerDate Sep<11>2014 17:15 Oct 06, 2014 Jkt 235001 information) about themselves that information will not usually be redacted. The NIOSH Freedom of Information Act (FOIA) coordinator will, however, review such revelations in accordance with the Federal Advisory Committee Act and if deemed appropriate, will redact such information. (3) If a commenter reveals personal information concerning a living third party, that information will be reviewed by the NIOSH FOIA coordinator, and upon determination, if deemed appropriated, such information will be redacted, unless the disclosure is made by the third party’s authorized representative under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA) program. (4) In general, information concerning a deceased third party may be disclosed; however, such information will be redacted if (a) the disclosure is made by an individual other than the survivor claimant, a parent, spouse, or child, or the authorized representative of the deceased third party; (b) if it is unclear whether the third party is living or deceased; or (c) the information is unrelated or irrelevant to the purpose of the disclosure. The Board will take reasonable steps to ensure that individuals making public comment are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public Web site. Such reasonable steps include: (a) A statement read at the start of each public comment period stating that transcripts will be posted and names of speakers will not be redacted; (b) A printed copy of the statement mentioned in (a) above will be displayed on the table where individuals sign up to make public comments; (c) A statement such as outlined in (a) above will also appear with the agenda for a Board Meeting when it is posted on the NIOSH Web site; (d) A statement such as in (a) above will appear in the Federal Register Notice that announces Board and Subcommittee meetings. Contact Person for More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E–20, Atlanta, Georgia 30333, telephone: (513) 533–6800, toll free: 1– 800–CDC–INFO, email: dcas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for the Centers for Disease Control and Prevention and PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 60473 the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–23855 Filed 10–6–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting for the aforementioned subcommittee: Date and Time: October 29, 2014, EST, 10:30 a.m.–5:00 p.m. Place: Audio Conference Call via FTS Conferencing. Status: Open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA tollfree, dial-in number, 1–866–659–0537 and the passcode is 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, E:\FR\FM\07OCN1.SGM 07OCN1

Agencies

[Federal Register Volume 79, Number 194 (Tuesday, October 7, 2014)]
[Notices]
[Pages 60472-60473]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23855]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH or Advisory 
Board), National Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:
    Time and Date: 8:15 a.m.-4:30 p.m., Pacific Daylight Time, November 
6, 2014.
    Public Comment Time and Date: 4:30 p.m.-5:30 p.m., Pacific Daylight 
Time, November 6, 2014.
    Place: Hilton Garden Inn Los Angeles/Redondo Beach, 2410 Marine 
Avenue, Redondo Beach, CA 90278, Phone: 310-727-9999; Fax: 310-727-
9998. Audio Conference Call via FTS Conferencing. The USA toll-free, 
dial-in number is 1-866-659-0537 with a pass code of 9933701.
    Live Meeting Connection: https://www.livemeeting.com/cc/cdc/join?id=ZN5GQZ&role=attend&pw=ABRWH; Meeting ID: ZN5GQZ; Entry Code: 
ABRWH.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 100 people.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines which have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule, advice on methods of dose reconstruction which have 
also been promulgated by HHS as a final rule, advice on the scientific

[[Page 60473]]

validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program, and advice on 
petitions to add classes of workers to the Special Exposure Cohort 
(SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2015.
    Purpose: This Advisory Board is charged with (a) providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advising the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class.
    Matters for Discussion: The agenda for the Advisory Board meeting 
includes: NIOSH Program Update; Department of Labor Program Update; 
Department of Energy Program Update; SEC Issues Work Group Report on 
``Sufficient Accuracy''/Co-Worker Dose Modeling; SEC Petitions Update; 
an update on SEC and Site Profile work for the Area IV of the Santa 
Susana Field Laboratory (Ventura County, CA); and Board Work Session.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may be 
submitted to the contact person below well in advance of the meeting. 
Any written comments received will be provided at the meeting in 
accordance with the redaction policy provided below.
    Policy on Redaction of Board Meeting Transcripts (Public Comment): 
(1) If a person making a comment gives his or her personal information, 
no attempt will be made to redact the name; however, NIOSH will redact 
other personally identifiable information, such as contact information, 
social security numbers, case numbers, etc., of the commenter.
    (2) If an individual in making a statement reveals personal 
information (e.g., medical or employment information) about themselves 
that information will not usually be redacted. The NIOSH Freedom of 
Information Act (FOIA) coordinator will, however, review such 
revelations in accordance with the Federal Advisory Committee Act and 
if deemed appropriate, will redact such information.
    (3) If a commenter reveals personal information concerning a living 
third party, that information will be reviewed by the NIOSH FOIA 
coordinator, and upon determination, if deemed appropriated, such 
information will be redacted, unless the disclosure is made by the 
third party's authorized representative under the Energy Employees 
Occupational Illness Compensation Program Act (EEOICPA) program.
    (4) In general, information concerning a deceased third party may 
be disclosed; however, such information will be redacted if (a) the 
disclosure is made by an individual other than the survivor claimant, a 
parent, spouse, or child, or the authorized representative of the 
deceased third party; (b) if it is unclear whether the third party is 
living or deceased; or (c) the information is unrelated or irrelevant 
to the purpose of the disclosure.
    The Board will take reasonable steps to ensure that individuals 
making public comment are aware of the fact that their comments 
(including their name, if provided) will appear in a transcript of the 
meeting posted on a public Web site. Such reasonable steps include: (a) 
A statement read at the start of each public comment period stating 
that transcripts will be posted and names of speakers will not be 
redacted; (b) A printed copy of the statement mentioned in (a) above 
will be displayed on the table where individuals sign up to make public 
comments; (c) A statement such as outlined in (a) above will also 
appear with the agenda for a Board Meeting when it is posted on the 
NIOSH Web site; (d) A statement such as in (a) above will appear in the 
Federal Register Notice that announces Board and Subcommittee meetings.
    Contact Person for More Information: Theodore Katz, Designated 
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta, 
Georgia 30333, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO, 
email: dcas@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2014-23855 Filed 10-6-14; 8:45 am]
BILLING CODE 4163-18-P